Physician profile
Vinay Sharma
NPI 1609984517
$1,763.07
in general payments reported to CMS, 2019-2025
22 companies · $24.79 in 2025
The $24.79 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $253 · 2021: $93.65 · 2022: $13.85 · 2023: $23.87 · 2025: $24.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $415.31 | 2019-2020 | |
| Glaxosmithkline, LLC. | $361.46 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $108.94 | 2020-2021 | |
| Philips North America LLC | $97.65 | 2019 | |
| Sunovion Pharmaceuticals INC. | $82.29 | 2019-2020 | |
| Shire North American Group INC | $77.18 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $72.08 | 2019-2020 | |
| Insmed, INC. | $60.13 | 2019-2025 | Arikayce |
| United Therapeutics Corporation | $48.10 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $42.85 | 2020-2023 | Terlivaz |
| Jazz Pharmaceuticals INC. | $42.22 | 2019-2020 | |
| Harmony Biosciences LLC | $37.90 | 2020 | |
| Genentech USA, INC. | $34.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $34.55 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $25.94 | 2019 | |
| Mylan Specialty L.P. | $25.81 | 2019 | |
| Genzyme Corporation | $25.26 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.01 | 2019 | |
| Mallinckrodt Enterprises LLC | $16.32 | 2019 | |
| Ge Healthcare | $13.85 | 2022 | |
| Resmed Corp | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.